Freschi ML - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Increase in body weight is lowered when mice received fecal microbiota transfer from donor mice treated with the AT₁ receptor antagonist telmisartan.

Freschi ML, Künstner A, Huber G, Stölting I, Busch H, Hirose M, Raasch W. Freschi ML, et al. Front Pharmacol. 2024 Nov 18;15:1453989. doi: 10.3389/fphar.2024.1453989. eCollection 2024. Front Pharmacol. 2024. PMID: 39624839 Free PMC article.

Telmisartan induces a specific gut microbiota signature which may mediate its antiobesity effect.

Beckmann L, Künstner A, Freschi ML, Huber G, Stölting I, Ibrahim SM, Hirose M, Freitag M, Langan EA, Matschl U, Galuska CE, Fuchs B, Knobloch JK, Busch H, Raasch W. Beckmann L, et al. Among authors: freschi ml. Pharmacol Res. 2021 Aug;170:105724. doi: 10.1016/j.phrs.2021.105724. Epub 2021 Jun 9. Pharmacol Res. 2021. PMID: 34116209

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Search Page

Filters